Scleroderma Diagnosis and Evaluation

Important blood tests and skin checks for early detection.

Clinical Immunology focuses on the immune system’s health. Learn about the diagnosis and treatment of allergies, autoimmune diseases, and immunodeficiencies.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Scleroderma: Diagnosis and Tests

Diagnosing scleroderma requires a detective’s mindset. Because the disease mimics other connective tissue disorders in its early stages, misdiagnosis is common. At Liv Hospital, we employ a rigorous, multi-modal diagnostic protocol that integrates clinical observation with advanced serological and imaging technology. The diagnosis is rarely made by a single “yes or no” test; rather, it is established by fulfilling a set of classification criteria, typically the 2013 ACR/EULAR criteria, which assigns points to various clinical features.

The Autoantibody Profile

The immunological footprint of scleroderma is distinct. Approximately 95% of patients will test positive for Antinuclear Antibody (ANA). However, the ANA pattern and the specific antibodies present provide a roadmap for diagnosis and prognosis.

Anti-Centromere Antibodies (ACA)

These antibodies are strongly associated with Limited Cutaneous Systemic Sclerosis (lcSSc). A positive result here suggests slower skin progression but alerts the clinician to closely monitor for Pulmonary Arterial Hypertension (PAH) in the future.

Anti-Scl-70 (Anti-Topoisomerase I)

This antibody is the hallmark of Diffuse Cutaneous Systemic Sclerosis (dcSSc). Its presence correlates with a higher risk of Interstitial Lung Disease (ILD) and significant skin fibrosis. Patients with this marker require aggressive early monitoring of lung function.

Anti-RNA Polymerase III

This marker identifies a subset of patients at rapid risk for extensive skin thickening and, critically, Scleroderma Renal Crisis (SRC). Identifying this antibody early is vital because it changes the management plan regarding blood pressure monitoring and steroid avoidance

Nailfold Capillaroscopy

Nailfold capillaroscopy is a non-invasive, highly sensitive diagnostic tool that differentiates primary Raynaud’s (benign) from secondary Raynaud’s (scleroderma-associated). By placing the finger under a microscope or a dermatoscope, the doctor visualizes the capillary loops.

The “Scleroderma Pattern”

In healthy individuals, capillaries are uniform, hairpin-shaped loops. In scleroderma, specific abnormalities occur:

Giant Capillaries: Enlarged, dilated loops indicating vessel stress.
Hemorrhages: Tiny areas of bleeding where vessels have ruptured.
Avascular Areas: Regions where capillaries have completely disappeared (dropout), indicating advanced vascular damage.

Pulmonary Evaluation: Structural and Functional

Given the high mortality associated with lung disease, pulmonary testing is comprehensive.

High-Resolution Computed Tomography (HRCT)

A standard chest X-ray is insufficient. HRCT provides detailed cross-sectional images of the lungs. Radiologists look for “ground-glass opacities” (indicating active inflammation) or “honeycombing” (indicating permanent fibrosis). This distinction determines whether immunosuppression will be adequate.

Pulmonary Function Tests (PFTs)

PFTs measure the mechanics of breathing. Two values are critical:

FVC (Forced Vital Capacity): Measures lung volume. A decline suggests restriction due to fibrosis.
DLCO (Diffusing Capacity of the Lung for Carbon Monoxide): Measures gas exchange. An isolated drop in DLCO (while FVC remains normal) is a red flag for Pulmonary Hypertension.

Cardiac Assessment

Transthoracic Echocardiogram

This ultrasound of the heart is the primary screening tool for Pulmonary Arterial Hypertension. It measures the velocity of the Tricuspid Regurgitation (TR) jet to estimate pressure in the pulmonary arteries. It also assesses the pericardium for fluid and the myocardium for stiffness.

Cardiac MRI

In cases where myocardial fibrosis is suspected, a Cardiac MRI may be ordered. It is more sensitive than an echo in detecting inflammation and scarring within the heart muscle itself.

Gastrointestinal Diagnostics

Esophagogastroduodenoscopy (EGD)

This procedure involves passing a camera down the throat to visualize the esophagus and stomach. It is used to diagnose Candida esophagitis, strictures, Barrett’s esophagus (precancerous changes), and GAVE.

Esophageal Manometry

This test measures the pressure and coordination of the esophageal muscles. In scleroderma, the classic finding is a “hypotensive lower esophageal sphincter” and “absent peristalsis” in the lower two-thirds of the esophagus, confirming the cause of swallowing difficulties.

Hydrogen Breath Testing

To diagnose Small Intestinal Bacterial Overgrowth (SIBO), patients drink a sugar solution and breathe into a specialized machine. Elevated hydrogen or methane levels in the breath indicate that bacteria in the small intestine are fermenting the sugar, confirming malabsorption.

Skin Biopsy

While less common now due to the reliability of antibody testing, a skin biopsy may be performed in atypical cases. A slight punch of skin is removed and examined by a pathologist. The findings of thickened collagen bundles in the reticular dermis, loss of skin appendages (hair follicles, sweat glands), and entrapment of fat cells are definitive for scleroderma. This is particularly useful for ruling out “scleroderma mimics” such as Scleromyxedema or Nephrogenic Systemic Fibrosis.

Assessment of Renal Function

Routine blood tests for creatinine and urea are standard. However, the most critical test for predicting renal crisis is simple blood pressure monitoring. Patients are often asked to keep a home log. Urinalysis is also performed to check for proteinuria (protein in urine) or hematuria (blood in urine), which can indicate early kidney stress.

Get an Online Consultation with
Certified Doctors

Related Doctors

Liv Hospital Ulus Assoc. Prof. MD. Selman Emiroğlu General Surgery

Liv Hospital Ulus Op. MD. Gökçe Aylaz General Surgery

Liv Hospital Ulus Prof. MD. Mehmet Levhi Akın General Surgery

Liv Hospital Vadistanbul Op. MD. Şeyma Karakuş General Surgery

Liv Hospital Vadistanbul Prof. MD. Onur Bayraktar General Surgery

Liv Hospital Bahçeşehir Assoc. Prof. MD. Mehmet Tokaç General Surgery

Liv Hospital Bahçeşehir Asst. Prof. MD. Alaaddin Aydın General Surgery

Liv Hospital Bahçeşehir Asst. Prof. MD. Musa Diri General Surgery

Liv Hospital Bahçeşehir Asst. Prof. MD. Tansu Altıntaş General Surgery

Liv Hospital Bahçeşehir MD. Eryiğit Eren General Surgery

Liv Hospital Bahçeşehir Op. MD. Rıdvan Gökay General Surgery

Liv Hospital Bahçeşehir Prof. MD. Ayhan Dinçkan General Surgery

Liv Hospital Bahçeşehir Prof. MD. M.A. Samet Bozkurt General Surgery

Liv Hospital Topkapı Asst. Prof. MD. Burak Kankaya General Surgery Liv Hospital Topkapı Asst. Prof. MD. Yusuf Emre Altundal General Surgery

Liv Hospital Topkapı Prof. MD. Halil Alış General Surgery

Liv Hospital Topkapı Prof. MD. Selin Kapan General Surgery

Liv Hospital Ankara Op. MD. Ahmet Turan Durak General Surgery

Liv Hospital Ankara Op. MD. Sera Yazıcı General Surgery

Liv Hospital Ankara Op. MD. Zafer Şahlı General Surgery

Liv Hospital Ankara Prof. MD. Ersin Gürkan Dumlu General Surgery

Liv Hospital Ankara Prof. MD. Hatim Yahya Uslu General Surgery

Liv Hospital Ankara Prof. MD. Sait Zafer Ferahköse General Surgery

Liv Hospital Gaziantep Op.MD. Ömer Söylemez General Surgery

Liv Hospital Gaziantep Prof. MD. İbrahim Yetim General Surgery

Liv Hospital Samsun Op. MD. Sultan Ayaz General Surgery

Liv Hospital Samsun Op. MD. Yılmaz Karagöz General Surgery

Liv Hospital Samsun Prof. MD. Recep Aktimur General Surgery

Liv Hospital Samsun Prof. MD. Serdar Yol General Surgery

Liv Bona Dea Hospital Bakü MD. EMİN BAYRAMOV General Surgery

Liv Bona Dea Hospital Bakü MD. LALE İSMAYILOVA General Surgery

Liv Bona Dea Hospital Bakü MD. GÜNAY ALLAHVERDİYEVA General Surgery

Liv Bona Dea Hospital Bakü MD. VÜQAR CEFEROV General Surgery

Liv Hospital Ulus + Liv Hospital Vadistanbul Prof. MD. Ahmet Cem Dural General Surgery

Liv Hospital Ulus + Liv Hospital Vadistanbul Prof. MD. Koray Acarlı General Surgery

30 Years of Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Reviews from 9,651

4,9

Worth a look

Was this article helpful?

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

FREQUENTLY ASKED QUESTIONS

Does a positive ANA test mean I have scleroderma?

Not necessarily. A positive ANA is seen in many autoimmune diseases and even in some healthy people. It must be interpreted alongside symptoms and specific scleroderma antibodies.

Is the nailfold capillaroscopy painful?

No, it is entirely painless. It is simply a microscopic view of the skin at the base of your fingernail, using oil and a lens.

Why do I need a heart ultrasound if I have no chest pain?

Pulmonary hypertension can be silent in its early stages. An echo is the only way to screen for it before severe symptoms develop.

How often do I need lung scans?

Typically, HRCT is done at diagnosis. If you have the diffuse subtype or markers for lung disease, it may be repeated periodically, but PFTs (breathing tests) are done more frequently (every 3-6 months).

What is the difference between an X-ray and HRCT?

An X-ray is a 2D image that misses fine details. HRCT produces thin-slice 3D images, allowing doctors to see lung tissue texture and detect very early scarring.